Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.

Lipids in health and disease·2019
Same author

Hybrid comprehensive telerehabilitation in heart failure patients (TELEREH-HF): A randomized, multicenter, prospective, open-label, parallel group controlled trial-Study design and description of the intervention.

American heart journal·2019
Same author

Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units.

Journal of clinical medicine·2019
Same author

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology.

Disease markers·2019
Same author

Association of Empirical Dietary Atherogenic Indices with All-Cause and Cause-Specific Mortality in a Multi-Ethnic Adult Population of the United States.

Nutrients·2019
Same author

Regulation of cardiac stem cells by microRNAs: State-of-the-art.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2019
Same journal

Heart Failure in Adult Congenital Heart Disease.

Methodist DeBakey cardiovascular journal·2026
Same journal

The Box: A Message from the Heart in 55 Words.

Methodist DeBakey cardiovascular journal·2026
Same journal

The Initial Diagnostic Approach to Adult Congenital Heart Disease: A Practical Imaging Pathway for General Cardiologists and Cardiac Imagers.

Methodist DeBakey cardiovascular journal·2026
Same journal

Unrepaired Congenital Shunt Lesions in Adults: Principles for Clinical Management.

Methodist DeBakey cardiovascular journal·2026
Same journal

Adult Congenital Heart Disease at the Crossroads of Innovation.

Methodist DeBakey cardiovascular journal·2026
Same journal

Transcatheter Edge-to-Edge Repair in Adult Congenital Heart Disease: Anatomic Challenges, Device Adaptations, and Emerging Evidence.

Methodist DeBakey cardiovascular journal·2026
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

17.9K

Statins: Then and Now.

Peter P Toth1,2, Maciej Banach3

  • 1CGH MEDICAL CENTER, STERLING, ILLINOIS.

Methodist Debakey Cardiovascular Journal
|May 4, 2019
PubMed
Summary
This summary is machine-generated.

Statins effectively lower cholesterol and reduce cardiovascular events like heart attacks and strokes. Despite proven benefits, long-term patient adherence and appropriate dosing remain significant challenges in cardiovascular disease prevention.

Keywords:
3-hydroxy-3-methylglutaryl-coenzyme A reductaseatherosclerosiscardiovascular eventslovastatinlow-density lipoprotein cholesterolmevastatin

More Related Videos

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
08:13

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart

Published on: September 13, 2011

28.1K
Multiparametric Optical Mapping of the Langendorff-perfused Rabbit Heart
09:24

Multiparametric Optical Mapping of the Langendorff-perfused Rabbit Heart

Published on: September 13, 2011

23.3K

Related Experiment Videos

Last Updated: Jan 25, 2026

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

17.9K
Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
08:13

Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart

Published on: September 13, 2011

28.1K
Multiparametric Optical Mapping of the Langendorff-perfused Rabbit Heart
09:24

Multiparametric Optical Mapping of the Langendorff-perfused Rabbit Heart

Published on: September 13, 2011

23.3K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Cholesterol biosynthesis inhibition led to statin discovery.
  • Lipoprotein cholesterol's role in atherogenesis is well-established.
  • Urgent need to quantify lipid-lowering impact on cardiovascular events.

Purpose of the Study:

  • Evaluate the efficacy and safety of statins in cardiovascular disease.
  • Assess the impact of statins on cardiovascular event rates and mortality.
  • Examine the evolution of statin dosing strategies and adherence challenges.

Main Methods:

  • Review of basic scientific, genetic, and clinical research.
  • Analysis of prospective randomized statin trials.
  • Assessment of clinical utility, tolerability, and mortality reduction.

Main Results:

  • Statins significantly reduce risks of nonfatal myocardial infarction, ischemic stroke, revascularization, and mortality.
  • Statins demonstrate efficacy, safety, and good tolerability in reducing atherogenic lipoprotein burden.
  • Established atherosclerotic plaque stabilization and regression observed with statin use.

Conclusions:

  • Statins are highly effective and safe for reducing cardiovascular risk and mortality.
  • Shift from LDL-C goals to risk-based and percentage reduction targets in statin therapy.
  • Low long-term adherence and underdosing of statins are critical issues requiring attention.